Skip to main content
. 2023 Feb 21;82(5):611–620. doi: 10.1136/ard-2022-222519

Table 3.

Results from ordered logistic regression models to determine the association between pre-treatment MRP8/14 and CDAI responses to TNFi

Model Number of cases OR (95% Cl) Pseudo R2 P value
MRP8/14 only 330 1.00 (0.99 to 1.01) 0.0000 0.839
MRP8/14 adjusted for pre-treatment CRP 330 1.00 (0.99 to 1.02) 0.0005 0.686

CDAI, clinical disease activity index; CRP, C reactive protein; TNFi, tumour necrosis factor inhibitor.